186 related articles for article (PubMed ID: 33845032)
1. Renin-angiotensin system inhibitors effect before and during hospitalization in COVID-19 outcomes: Final analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry.
Núñez-Gil IJ; Olier I; Feltes G; Viana-Llamas MC; Maroun-Eid C; Romero R; Fernández-Rozas I; Uribarri A; Becerra-Muñoz VM; Alfonso-Rodriguez E; García-Aguado M; Elola J; Castro-Mejía A; Pepe M; Garcia-Prieto JF; Gonzalez A; Ugo F; Cerrato E; Bondia E; Raposeiras-Roubin S; Mendez JLJ; Espejo C; López-Masjuan Á; Marin F; López-Pais J; Abumayyaleh M; Corbi-Pascual M; Liebetrau C; Ramakrishna H; Estrada V; Macaya C; Fernandez-Ortiz A;
Am Heart J; 2021 Jul; 237():104-115. PubMed ID: 33845032
[TBL] [Abstract][Full Text] [Related]
2. Renin-angiotensin system modulation and outcomes in patients hospitalized for interstitial SARS-CoV2 pneumonia: a cohort study.
Landolfo M; Maino A; Di Salvo E; Fiorini G; Peterlana D; Borghi C
Intern Emerg Med; 2022 Aug; 17(5):1335-1341. PubMed ID: 35064437
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of Combined Renin-Angiotensin System Inhibitors and Diuretic Treatment In Patients Hospitalized with COVID-19.
Palazzuoli A; Tecson KM; Vicenzi M; D'Ascenzo F; De Ferrari GM; Monticone S; Secco GG; Tavazzi G; Forleo G; Severino P; Fedele F; De Rosa F; McCullough PA
Am J Cardiol; 2022 Mar; 167():133-138. PubMed ID: 35027137
[TBL] [Abstract][Full Text] [Related]
4. Impact of renin-angiotensin system inhibitors on mortality during the COVID Pandemic among STEMI patients undergoing mechanical reperfusion: Insight from an international STEMI registry.
De Luca G; Cercek M; Okkels Jensen L; Bushljetikj O; Calmac L; Johnson T; Gracida Blancas M; Ganyukov V; Wojakowski W; von Birgelen C; IJsselmuiden A; Tuccillo B; Versaci F; Ten Berg J; Laine M; Berkout T; Casella G; Kala P; López Ledesma B; Becerra V; Padalino R; Santucci A; Carrillo X; Scoccia A; Amoroso G; Lux A; Kovarnik T; Davlouros P; Gabrielli G; Flores Rios X; Bakraceski N; Levesque S; Guiducci V; Kidawa M; Marinucci L; Zilio F; Galasso G; Fabris E; Menichelli M; Manzo S; Caiazzo G; Moreu J; Sanchis Forés J; Donazzan L; Vignali L; Teles R; Agostoni P; Bosa Ojeda F; Lehtola H; Camacho-Freiere S; Kraaijeveld A; Antti Y; Visconti G; Lozano Martínez-Luengas I; Scheller B; Alexopulos D; Moreno R; Kedhi E; Uccello G; Faurie B; Gutierrez Barrios A; Scotto Di Uccio F; Wilbert B; Cortese G; Dirksen MT; Parodi G; Verdoia M
Biomed Pharmacother; 2021 Jun; 138():111469. PubMed ID: 33740523
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 and the impact of arterial hypertension-An analysis of the international HOPE COVID-19 Registry (Italy-Spain-Germany).
El-Battrawy I; Nuñez-Gil IJ; Abumayyaleh M; Estrada V; Manuel Becerra-Muñoz V; Uribarri A; Fernández-Rozas I; Feltes G; Arroyo-Espliguero R; Trabattoni D; López-País J; Pepe M; Romero R; Castro-Mejía AF; Cerrato E; Capel Astrua T; D'Ascenzo F; Fabregat-Andres O; Signes-Costa J; Marín F; Buonsenso D; Bardají A; Jesús Tellez M; Fernández-Ortiz A; Macaya C; Akin I
Eur J Clin Invest; 2021 Nov; 51(11):e13582. PubMed ID: 34409593
[TBL] [Abstract][Full Text] [Related]
6. Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial.
Cohen JB; Hanff TC; William P; Sweitzer N; Rosado-Santander NR; Medina C; Rodriguez-Mori JE; Renna N; Chang TI; Corrales-Medina V; Andrade-Villanueva JF; Barbagelata A; Cristodulo-Cortez R; Díaz-Cucho OA; Spaak J; Alfonso CE; Valdivia-Vega R; Villavicencio-Carranza M; Ayala-García RJ; Castro-Callirgos CA; González-Hernández LA; Bernales-Salas EF; Coacalla-Guerra JC; Salinas-Herrera CD; Nicolosi L; Basconcel M; Byrd JB; Sharkoski T; Bendezú-Huasasquiche LE; Chittams J; Edmonston DL; Vasquez CR; Chirinos JA
Lancet Respir Med; 2021 Mar; 9(3):275-284. PubMed ID: 33422263
[TBL] [Abstract][Full Text] [Related]
7. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
8. Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Blockers With Severity of COVID-19: A Multicenter, Prospective Study.
Hakeam HA; Alsemari M; Duhailib ZA; Ghonem L; Alharbi SA; Almutairy E; Sheraim NMB; Alsalhi M; Alhijji A; AlQahtani S; Khalid M; Barry M
J Cardiovasc Pharmacol Ther; 2021 May; 26(3):244-252. PubMed ID: 33231487
[TBL] [Abstract][Full Text] [Related]
9. Renin-Angiotensin System Inhibitors in Patients With COVID-19: A Meta-Analysis of Randomized Controlled Trials Led by the International Society of Hypertension.
Gnanenthiran SR; Borghi C; Burger D; Caramelli B; Charchar F; Chirinos JA; Cohen JB; Cremer A; Di Tanna GL; Duvignaud A; Freilich D; Gommans DHF; Gracia-Ramos AE; Murray TA; Pelorosso F; Poulter NR; Puskarich MA; Rizas KD; Rothlin R; Schlaich MP; Schreinlecher M; Steckelings UM; Sharma A; Stergiou GS; Tignanelli CJ; Tomaszewski M; Unger T; van Kimmenade RRJ; Wainford RD; Williams B; Rodgers A; Schutte AE;
J Am Heart Assoc; 2022 Sep; 11(17):e026143. PubMed ID: 36000426
[TBL] [Abstract][Full Text] [Related]
10. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.
Grasselli G; Greco M; Zanella A; Albano G; Antonelli M; Bellani G; Bonanomi E; Cabrini L; Carlesso E; Castelli G; Cattaneo S; Cereda D; Colombo S; Coluccello A; Crescini G; Forastieri Molinari A; Foti G; Fumagalli R; Iotti GA; Langer T; Latronico N; Lorini FL; Mojoli F; Natalini G; Pessina CM; Ranieri VM; Rech R; Scudeller L; Rosano A; Storti E; Thompson BT; Tirani M; Villani PG; Pesenti A; Cecconi M;
JAMA Intern Med; 2020 Oct; 180(10):1345-1355. PubMed ID: 32667669
[TBL] [Abstract][Full Text] [Related]
11. Antecedent Administration of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Antagonists and Survival After Hospitalization for COVID-19 Syndrome.
Palazzuoli A; Mancone M; De Ferrari GM; Forleo G; Secco GG; Ruocco GM; D'Ascenzo F; Monticone S; Paggi A; Vicenzi M; Palazzo AG; Landolina M; Taravelli E; Tavazzi G; Blasi F; Infusino F; Fedele F; De Rosa FG; Emmett M; Schussler JM; Tecson KM; McCullough PA
J Am Heart Assoc; 2020 Nov; 9(22):e017364. PubMed ID: 33023356
[TBL] [Abstract][Full Text] [Related]
12. The effects of renin-angiotensin system inhibitors (RASI) in coronavirus disease (COVID-19) with hypertension: A retrospective, single-center trial.
Cui H; Wu F; Fan Z; Cheng X; Cheng J; Fan M
Med Clin (Barc); 2020 Oct; 155(7):295-298. PubMed ID: 32747012
[TBL] [Abstract][Full Text] [Related]
13. Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 in a western population. CARDIOVID registry.
López-Otero D; López-Pais J; Cacho-Antonio CE; Antúnez-Muiños PJ; González-Ferrero T; Pérez-Poza M; Otero-García Ó; Díaz-Fernández B; Bastos-Fernández M; Bouzas-Cruz N; Sanmartín-Pena XC; Varela-Román A; Portela-Romero M; Valdés-Cuadrado L; Pose-Reino A; González-Juanatey JR
Rev Esp Cardiol (Engl Ed); 2021 Feb; 74(2):175-182. PubMed ID: 32600991
[TBL] [Abstract][Full Text] [Related]
14. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; Brophy J; Afillalo J; Huynh T; Giannetti N; Bessissow A; Ezekowitz JA; Lopes RD; Ambrosy AP; Craig M; Sharma A
Trials; 2021 Feb; 22(1):115. PubMed ID: 33546734
[TBL] [Abstract][Full Text] [Related]
15. Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients.
Trifirò G; Massari M; Da Cas R; Menniti Ippolito F; Sultana J; Crisafulli S; Giorgi Rossi P; Marino M; Zorzi M; Bovo E; Leoni O; Ludergnani M; Spila Alegiani S;
Drug Saf; 2020 Dec; 43(12):1297-1308. PubMed ID: 32852721
[TBL] [Abstract][Full Text] [Related]
16. Clinical profile and prognosis in patients on oral anticoagulation before admission for COVID-19.
Rivera-Caravaca JM; Núñez-Gil IJ; Vivas D; Viana-Llamas MC; Uribarri A; Becerra-Muñoz VM; Trabattoni D; Fernández Rozas I; Feltes G; López-Pais J; El-Battrawy I; Macaya C; Fernandez-Ortiz A; Estrada V; Marín F;
Eur J Clin Invest; 2021 Jan; 51(1):e13436. PubMed ID: 33080051
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of COVID-19 Hospitalized Patients Previously Treated with Renin-Angiotensin System Inhibitors.
Cordeanu EM; Jambert L; Severac F; Lambach H; Tousch J; Heitz M; Mirea C; Hamadé A; Younes W; Frantz AS; Merdji H; Schini-Kerth V; Bilbault P; Meziani F; Ohlmann P; Andres E; Stephan D
J Clin Med; 2020 Oct; 9(11):. PubMed ID: 33126565
[TBL] [Abstract][Full Text] [Related]
18. Mortality risk assessment in Spain and Italy, insights of the HOPE COVID-19 registry.
Núñez-Gil IJ; Fernández-Pérez C; Estrada V; Becerra-Muñoz VM; El-Battrawy I; Uribarri A; Fernández-Rozas I; Feltes G; Viana-Llamas MC; Trabattoni D; López-País J; Pepe M; Romero R; Castro-Mejía AF; Cerrato E; Astrua TC; D'Ascenzo F; Fabregat-Andres O; Moreu J; Guerra F; Signes-Costa J; Marín F; Buosenso D; Bardají A; Raposeiras-Roubín S; Elola J; Molino Á; Gómez-Doblas JJ; Abumayyaleh M; Aparisi Á; Molina M; Guerri A; Arroyo-Espliguero R; Assanelli E; Mapelli M; García-Acuña JM; Brindicci G; Manzone E; Ortega-Armas ME; Bianco M; Trung CP; Núñez MJ; Castellanos-Lluch C; García-Vázquez E; Cabello-Clotet N; Jamhour-Chelh K; Tellez MJ; Fernández-Ortiz A; Macaya C;
Intern Emerg Med; 2021 Jun; 16(4):957-966. PubMed ID: 33165755
[TBL] [Abstract][Full Text] [Related]
19. Association between renin-angiotensin system inhibitor use and mortality/morbidity in elderly patients with heart failure with reduced ejection fraction: a prospective propensity score-matched cohort study.
Savarese G; Dahlström U; Vasko P; Pitt B; Lund LH
Eur Heart J; 2018 Dec; 39(48):4257-4265. PubMed ID: 30351407
[TBL] [Abstract][Full Text] [Related]
20. Use of renin-angiotensin system inhibitors and clinical predictors of COVID-19 severity in a tertiary hospital in the city of Buenos Aires.
Barochiner J; Martínez R; Conti PR; Marín MJ; Ko EA; Osorno MS
Infez Med; 2021 Jun; 29(2):209-215. PubMed ID: 34061785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
